These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32876693)

  • 1. Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic.
    Prescott HC; Rice TW
    JAMA; 2020 Oct; 324(13):1292-1295. PubMed ID: 32876693
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
    Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
    CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?
    Nicolau DV; Bafadhel M
    Lancet Respir Med; 2020 Sep; 8(9):846-847. PubMed ID: 32738928
    [No Abstract]   [Full Text] [Related]  

  • 4. Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19.
    Goursaud S; Descamps R; Daubin C; du Cheyron D; Valette X
    J Infect; 2020 Aug; 81(2):e89-e90. PubMed ID: 32417314
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous ventilation of two simulated ARDS patients in COVID-19 pandemic.
    Epstein D; Hoffman Y; Dahoud G; Raz A; Miller A
    Crit Care; 2020 May; 24(1):214. PubMed ID: 32393390
    [No Abstract]   [Full Text] [Related]  

  • 6. On the use of corticosteroids for 2019-nCoV pneumonia.
    Shang L; Zhao J; Hu Y; Du R; Cao B
    Lancet; 2020 Feb; 395(10225):683-684. PubMed ID: 32122468
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective.
    Halpin DMG; Singh D; Hadfield RM
    Eur Respir J; 2020 May; 55(5):. PubMed ID: 32341100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease.
    Taboada M; Caruezo V; Naveira A; Atanassoff PG
    J Clin Anesth; 2020 Nov; 66():109926. PubMed ID: 32474331
    [No Abstract]   [Full Text] [Related]  

  • 9. Corticosteroids, COVID-19 pneumonia, and acute respiratory distress syndrome.
    Matthay MA; Wick KD
    J Clin Invest; 2020 Dec; 130(12):6218-6221. PubMed ID: 32976118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient with severe COVID-19 treated with corticosteroids.
    Ofstad EH; Hauglid T; Tollåli T; Vasiljevic KR; Dybwik K
    Tidsskr Nor Laegeforen; 2020 Sep; 140(12):. PubMed ID: 32900168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis.
    Hasan SS; Capstick T; Ahmed R; Kow CS; Mazhar F; Merchant HA; Zaidi STR
    Expert Rev Respir Med; 2020 Nov; 14(11):1149-1163. PubMed ID: 32734777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Audio Interview: Dexamethasone and Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Jul; 383(4):e52. PubMed ID: 32706553
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute respiratory distress syndrome and steroids in the shadow of coronavirus disease 2019.
    Jaeschke R
    Pol Arch Intern Med; 2020 Apr; 130(4):266-267. PubMed ID: 32383835
    [No Abstract]   [Full Text] [Related]  

  • 14. [Not Available].
    Kan B; Ahl M; Blennow O; Eriksson P; Nowak P; Parke Å; Stojanovic B; Tovatt T; Vesterbacka J
    Lakartidningen; 2020 Oct; 117():. PubMed ID: 33021326
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs.
    Georgiev T
    Rheumatol Int; 2020 May; 40(5):825-826. PubMed ID: 32232552
    [No Abstract]   [Full Text] [Related]  

  • 16. A Review of the Evidence for Corticosteroids in COVID-19.
    Johns M; George S; Taburyanskaya M; Poon YK
    J Pharm Pract; 2022 Aug; 35(4):626-637. PubMed ID: 33719698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.
    Zhou W; Liu Y; Tian D; Wang C; Wang S; Cheng J; Hu M; Fang M; Gao Y
    Signal Transduct Target Ther; 2020 Feb; 5(1):18. PubMed ID: 32296012
    [No Abstract]   [Full Text] [Related]  

  • 18. WHO recommends corticosteroids for patients with severe or critical COVID-19.
    Keyt H
    Ann Intern Med; 2021 Jan; 174(1):JC2. PubMed ID: 33395337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
    Caocci G; La Nasa G
    Ann Hematol; 2020 Jul; 99(7):1675-1676. PubMed ID: 32405693
    [No Abstract]   [Full Text] [Related]  

  • 20. Prescribing COVID-19 treatments: what we should never forget.
    Tunesi S; Bourgarit A
    J Infect; 2020 Aug; 81(2):e85. PubMed ID: 32405110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.